Literature DB >> 35475554

Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.

Andreea Chiorean1, Kirsten M Farncombe2, Sean Delong1, Veronica Andric1, Safa Ansar1, Clarissa Chan1, Kaitlin Clark3,4, Arpad M Danos3,4, Yizhuo Gao1, Rachel H Giles5, Anna Goldenberg6, Payal Jani1, Kilannin Krysiak3,4, Lynzey Kujan3,4, Samantha Macpherson1, Eamonn R Maher7,8, Liam G McCoy1, Yasser Salama1, Jason Saliba3,4, Lana Sheta3,4, Malachi Griffith3,4, Obi L Griffith3,4, Lauren Erdman6, Arun Ramani6, Raymond H Kim9,10,11,12.   

Abstract

Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome where individuals are predisposed to tumor development in the brain, adrenal gland, kidney, and other organs. It is caused by pathogenic variants in the VHL tumor suppressor gene. Standardized disease information has been difficult to collect due to the rarity and diversity of VHL patients. Over 4100 unique articles published until October 2019 were screened for germline genotype-phenotype data. Patient data were translated into standardized descriptions using Human Genome Variation Society gene variant nomenclature and Human Phenotype Ontology terms and has been manually curated into an open-access knowledgebase called Clinical Interpretation of Variants in Cancer. In total, 634 unique VHL variants, 2882 patients, and 1991 families from 427 papers were captured. We identified relationship trends between phenotype and genotype data using classic statistical methods and spectral clustering unsupervised learning. Our analyses reveal earlier onset of pheochromocytoma/paraganglioma and retinal angiomas, phenotype co-occurrences and genotype-phenotype correlations including hotspots. It confirms existing VHL associations and can be used to identify new patterns and associations in VHL disease. Our database serves as an aggregate knowledge translation tool to facilitate sharing information about the pathogenicity of VHL variants.
© 2022 The Authors. Human Mutation published by Wiley Periodicals LLC.

Entities:  

Keywords:  CIViC; Von Hippel-Lindau; genotype-phenotype; machine learning; spectral clustering

Mesh:

Substances:

Year:  2022        PMID: 35475554      PMCID: PMC9356987          DOI: 10.1002/humu.24392

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.700


  58 in total

1.  Evidence for genetic anticipation in vonHippel-Lindau syndrome.

Authors:  M Stephen Meyn; Harriet Druker; Laura Aronoff; David Malkin; Kalene van Engelen; Bailey Gallinger; Jonathan Wasserman; Raymond H Kim; Anita Villani
Journal:  J Med Genet       Date:  2018-02-07       Impact factor: 6.318

2.  Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.

Authors:  A H Prowse; A R Webster; F M Richards; S Richard; S Olschwang; F Resche; N A Affara; E R Maher
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  ClinGen--the Clinical Genome Resource.

Authors:  Heidi L Rehm; Jonathan S Berg; Lisa D Brooks; Carlos D Bustamante; James P Evans; Melissa J Landrum; David H Ledbetter; Donna R Maglott; Christa Lese Martin; Robert L Nussbaum; Sharon E Plon; Erin M Ramos; Stephen T Sherry; Michael S Watson
Journal:  N Engl J Med       Date:  2015-05-27       Impact factor: 91.245

4.  Von hippel-lindau disease.

Authors:  Frederik J Hes; Jo Wm Höppener; Rob B van der Luijt; Cornelis Jm Lips
Journal:  Hered Cancer Clin Pract       Date:  2005-11-15       Impact factor: 2.857

5.  Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene.

Authors:  F M Richards; S J Payne; B Zbar; N A Affara; M A Ferguson-Smith; E R Maher
Journal:  Hum Mol Genet       Date:  1995-11       Impact factor: 6.150

Review 6.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

7.  Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.

Authors:  F M Richards; P N Schofield; S Fleming; E R Maher
Journal:  Hum Mol Genet       Date:  1996-05       Impact factor: 6.150

Review 8.  Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T).

Authors:  Daniela Alosi; Marie Luise Bisgaard; Sophie Nowak Hemmingsen; Lotte Nylandsted Krogh; Hanne Birte Mikkelsen; Marie Louise Mølgaard Binderup
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

9.  Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.

Authors:  Sebastian Köhler; Leigh Carmody; Nicole Vasilevsky; Julius O B Jacobsen; Daniel Danis; Jean-Philippe Gourdine; Michael Gargano; Nomi L Harris; Nicolas Matentzoglu; Julie A McMurry; David Osumi-Sutherland; Valentina Cipriani; James P Balhoff; Tom Conlin; Hannah Blau; Gareth Baynam; Richard Palmer; Dylan Gratian; Hugh Dawkins; Michael Segal; Anna C Jansen; Ahmed Muaz; Willie H Chang; Jenna Bergerson; Stanley J F Laulederkind; Zafer Yüksel; Sergi Beltran; Alexandra F Freeman; Panagiotis I Sergouniotis; Daniel Durkin; Andrea L Storm; Marc Hanauer; Michael Brudno; Susan M Bello; Murat Sincan; Kayli Rageth; Matthew T Wheeler; Renske Oegema; Halima Lourghi; Maria G Della Rocca; Rachel Thompson; Francisco Castellanos; James Priest; Charlotte Cunningham-Rundles; Ayushi Hegde; Ruth C Lovering; Catherine Hajek; Annie Olry; Luigi Notarangelo; Morgan Similuk; Xingmin A Zhang; David Gómez-Andrés; Hanns Lochmüller; Hélène Dollfus; Sergio Rosenzweig; Shruti Marwaha; Ana Rath; Kathleen Sullivan; Cynthia Smith; Joshua D Milner; Dorothée Leroux; Cornelius F Boerkoel; Amy Klion; Melody C Carter; Tudor Groza; Damian Smedley; Melissa A Haendel; Chris Mungall; Peter N Robinson
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  VariantValidator: Accurate validation, mapping, and formatting of sequence variation descriptions.

Authors:  Peter J Freeman; Reece K Hart; Liam J Gretton; Anthony J Brookes; Raymond Dalgleish
Journal:  Hum Mutat       Date:  2017-10-17       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.